MR spectroscopy, PET identify early Alzheimer’s risk
Using proton MR spectroscopy and PET, researchers from the Mayo Clinic in Rochester, MN, have identified significantly high levels of amyloid-beta deposits and other abnormalities in cognitively normal people with early signs of Alzheimer’s disease, according to research in the August 24 online issue of Neurology.
The researchers found that individuals with high levels of amyloid-beta deposits also tend to have high levels of brain metabolites such as choline, which reduce cognitive skills, regardless of the amount of amyloid-beta deposits in their brains.
New Data Shows Decline in Medical Imaging Utilization
A new analysis of Medicare data finds that spending on medical imaging continues to decline and that Medicare patients are receiving fewer imaging procedures. Learn More
MITA Now Includes Radiopharmaceutical Industry in Membership
With new membership MITA unites both halves of nuclear medicine. Learn More
CT Lung Cancer Screening Named Top Five Advance in 2011
The American Society of Clinical Oncology (ASCO) named CT-based lung cancer screening amongst 2011’s top five advances in its annual report on progress against cancer. Learn More
- © 2012 National Electrical Manufacturers Association |
- Privacy Policy |
- Terms & Conditions